Walgreens Boots Alliance, which is being taken private by Sycamore Partners, beat analysts' estimates for third-quarter ...

News that Walgreens quarterly loss was better than expected and pharmacy sales were rising bodes well for a turnaround under ...

Walgreens posted quarterly earnings that beat analyst expectations this morning, a potentially positive sign before going ...

Store closures and weak front-of-store comps led to a retail sales decline in Q3, but U.S. pharmacy and international sales ...

Walgreens faces a potential buyout by Sycamore Partners amid declining profits and heavy debt. Click here to read my earnings ...

The drugstore industry is facing competition from the likes of Amazon.com Inc., as well as pressure on pharmacy-reimbursement ...

Boots has continued to defy high street challenges with a 5% rise in total sales for the three months to the end of May ...

The Dow traded up 0.82% to 43,335.29 while the NASDAQ gained 0.69% to 20,110.81. The S&P 500 also rose, gaining, 0.66% to ...

Private equity firm Sycamore Partners has entered into a definitive agreement with Walgreens Boots Alliance to acquire the struggling retail pharmacy chain. Sycamore has agreed to pay $11.45 per ...

Walgreens in March agreed to be taken private by PE firm Sycamore Partners for $10 billion, closing out nearly a century of trading on public markets for the U.S. pharmacy giant.

It’s one of the last financial reports for Walgreens before it transitions to a private company in a deal with private equity firm Sycamore Partners. Walgreens also withdrew its 2025 financial ...

Sen. Elizabeth Warren is demanding answers from Sycamore Partners over its proposed $10 billion acquisition of Walgreens, warning the deal could threaten healthcare access for Massachusetts residents.